Home » Topics » Regulatory

Regulatory
RSS

FDA grants accelerated approval to Venclexta for relapsed/refractory CLL with 17p deletion

April 12, 2016

FDA approves BromSite to prevent pain and treat inflammation following cataract surgery

April 11, 2016

FDA approves Gilead's Descovy for the treatment of HIV

April 5, 2016

FDA approves Cinqair injection

March 24, 2016

Lilly's ixekizumab approved in the U.S. for plaque psoriasis

March 23, 2016

FDA first to approve Anthim for inhalation anthrax

March 22, 2016

FDA approves Xalkori for ROS1-positive metastatic NSCLC

March 14, 2016

FDA approves Odefsey single-tablet regimen for HIV-1 infection

March 2, 2016

FDA approves Gazyva for use in follicular lymphoma

Feb. 29, 2016

Takeda's combination packs for H. pylori eradication approved in Japan

Feb. 26, 2016

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...